Multiple Dose Pharmacokinetics of LCZ696 and Its Metabolites in Subjects With Severe Renal Impairment vs. Matched Healthy Subjects With Normal Renal Function

NCT01569828 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Pharmacokinetics
Renal Impaired
Healthy Volunteer

Interventions

DRUG: LCZ696A
DRUG: LCZ696A

Sponsor

Novartis Pharmaceuticals